Monteiro L M
Clin Neuropharmacol. 1985;8(4):372-6. doi: 10.1097/00002826-198512000-00008.
Tardive dyskinesia appeared in a 17-year-old boy following withdrawal of pimozide (Orap) and thioridazine (Melleril). The choreodyskinetic movements, which were limited to the limbs and the trunk, cleared with anticholinergic drugs but were dramatically worsened by dopaminergic receptor blockers. Therefore, therapy with an initial high dose of benztropine mesylate (Cogentin) associated with bromazepam (Lexotan) was instituted and was well tolerated.
一名17岁男孩在停用匹莫齐特(奥氮平)和硫利达嗪(美立廉)后出现迟发性运动障碍。舞蹈样运动障碍仅限于四肢和躯干,使用抗胆碱能药物后症状缓解,但多巴胺能受体阻滞剂使其症状显著恶化。因此,开始采用大剂量甲磺酸苯扎托品(安坦)联合溴西泮(溴安定)进行治疗,患者耐受性良好。